2017 Feb Merav Jacobson Bensky, Irit Ayalon-Dangur, Roi Ayalon-Dangur, Eviatar Naamany, Anat Gafter-Gvili, Gideon Koren, Shachaf Shiber
Not because of safety concerns per se, but because it becomes impossible to know whats actually working
Derived from a protective protein found in gastric juice, BPC-157 has demonstrated remarkable healing properties across a broad range of tissues in preclinical studies, including tendons, ligaments, muscles, bone, and the gastrointestinal tract
Some advantages of the compounds overlap, making the mix fairly highly effective
The maximum retatrutide dose currently being studied in major Phase 3 obesity trials is 12mg once weekly